Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily E Helman

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer Letters|November 8, 2008
EMMPRIN expression is required for response to bevacizumab therapy in HNSCC xenograftsJ Robert Newman, Emily E Helman, Seena Safavy, et al.
The Laryngoscope|October 25, 2011
Disruption of the AKT pathway inhibits metastasis in an orthotopic model of head and neck squamous cell carcinomaJoseph A Knowles, Blake Golden, Li Yan, et al.
Cancer Biology & Therapy|May 28, 2010
Optical imaging predicts tumor response to anti-EGFR therapyEmily E Helman, J Robert Newman, Nichole R Dean, et al.
Comparative Medicine|September 14, 2022
Ferret Systemic Coronavirus in Alpha-1 Antitrypsin Knockout FerretsAndrea J Osborne, Shah S Hussain, Emily E Helman, et al.
Head & Neck|July 9, 2011
EGFR expression in advanced head and neck cutaneous squamous cell carcinomaLarissa Sweeny, Nichole R Dean, J Scott Magnuson, et al.
Anti-Cancer Drugs|August 12, 2010
Anti-EMMPRIN antibody treatment of head and neck squamous cell carcinoma in an ex-vivo modelNichole Renae Dean, Joseph A Knowles, Emily E Helman, et al.
Scientific Reports|April 19, 2026
Harnessing Id1 as a biomarker in a plasmid reporter system for cervical cancerAbbigael V Eli, Benjamin B Kasten, Yolanda Hartman, et al.
Anti-Cancer Drugs|July 7, 2011
Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapyHyunki Kim, Guihua Zhai, Zhiyong Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancerNichole R Dean, J Robert Newman, Emily E Helman, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Letters|November 8, 2008
EMMPRIN expression is required for response to bevacizumab therapy in HNSCC xenograftsJ Robert Newman, Emily E Helman, Seena Safavy, et al.
The Laryngoscope|October 25, 2011
Disruption of the AKT pathway inhibits metastasis in an orthotopic model of head and neck squamous cell carcinomaJoseph A Knowles, Blake Golden, Li Yan, et al.
Cancer Biology & Therapy|May 28, 2010
Optical imaging predicts tumor response to anti-EGFR therapyEmily E Helman, J Robert Newman, Nichole R Dean, et al.
Comparative Medicine|September 14, 2022
Ferret Systemic Coronavirus in Alpha-1 Antitrypsin Knockout FerretsAndrea J Osborne, Shah S Hussain, Emily E Helman, et al.
Head & Neck|July 9, 2011
EGFR expression in advanced head and neck cutaneous squamous cell carcinomaLarissa Sweeny, Nichole R Dean, J Scott Magnuson, et al.
Anti-Cancer Drugs|August 12, 2010
Anti-EMMPRIN antibody treatment of head and neck squamous cell carcinoma in an ex-vivo modelNichole Renae Dean, Joseph A Knowles, Emily E Helman, et al.
Scientific Reports|April 19, 2026
Harnessing Id1 as a biomarker in a plasmid reporter system for cervical cancerAbbigael V Eli, Benjamin B Kasten, Yolanda Hartman, et al.
Anti-Cancer Drugs|July 7, 2011
Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapyHyunki Kim, Guihua Zhai, Zhiyong Liu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Anti-EMMPRIN monoclonal antibody as a novel agent for therapy of head and neck cancerNichole R Dean, J Robert Newman, Emily E Helman, et al.
Pageof 1